Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney

por Viazzi, Francesca, Leoncini, Giovanna, Pontremoli, Roberto
Publicado 2013

Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system

por Viazzi, Francesca, Leoncini, Giovanna, Pontremoli, Roberto
Publicado 2013

Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection

por Kielstein, Jan T., Pontremoli, Roberto, Burnier, Michel
Publicado 2020

Renal protection in chronic heart failure: focus on sacubitril/valsartan

por Pontremoli, Roberto, Borghi, Claudio, Perrone Filardi, Pasquale
Publicado 2021

Chronic kidney disease as a predictor of clinical risk in the elderly

por Viazzi, Francesca, Cappadona, Francesca, Bonino, Barbara, Pontremoli, Roberto
Publicado 2016

Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient

por Viazzi, Francesca, Leoncini, Giovanna, Derchi, Lorenzo E., Pontremoli, Roberto
Publicado 2014

Serum Uric Acid Levels Predict New-Onset Type 2 Diabetes in Hospitalized Patients With Primary Hypertension: The MAGIC Study

por Viazzi, Francesca, Leoncini, Giovanna, Vercelli, Marina, Deferrari, Giacomo, Pontremoli, Roberto
Publicado 2011

Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age

por Russo, Elisa, Leoncini, Giovanna, Esposito, Pasquale, Garibotto, Giacomo, Pontremoli, Roberto, Viazzi, Francesca
Publicado 2020

SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits

por Leoncini, Giovanna, Russo, Elisa, Bussalino, Elisabetta, Barnini, Cecilia, Viazzi, Francesca, Pontremoli, Roberto
Publicado 2021

Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations

por Leoncini, Giovanna, Viazzi, Francesca, De Cosmo, Salvatore, Russo, Giuseppina, Fioretto, Paola, Pontremoli, Roberto
Publicado 2020

Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?

por De Nicola, Luca, Cozzolino, Mario, Genovesi, Simonetta, Gesualdo, Loreto, Grandaliano, Giuseppe, Pontremoli, Roberto
Publicado 2022

GLP-1 Receptor Agonists and Kidney Protection

por Greco, Eulalia Valentina, Russo, Giuseppina, Giandalia, Annalisa, Viazzi, Francesca, Pontremoli, Roberto, De Cosmo, Salvatore
Publicado 2019

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet

por Russo, Elisa, Verzola, Daniela, Leoncini, Giovanna, Cappadona, Francesca, Esposito, Pasquale, Pontremoli, Roberto, Viazzi, Francesca
Publicado 2021

Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4

por Verzola, Daniela, Ratto, Elena, Villaggio, Barbara, Parodi, Emanuele Luigi, Pontremoli, Roberto, Garibotto, Giacomo, Viazzi, Francesca
Publicado 2014

Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach

por Bonino, Barbara, Leoncini, Giovanna, De Cosmo, Salvatore, Greco, Eulalia, Russo, Giuseppina T., Giandalia, Annalisa, Viazzi, Francesca, Pontremoli, Roberto
Publicado 2019

Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components

por Russo, Elisa, Bussalino, Elisabetta, Macciò, Lucia, Verzola, Daniela, Saio, Michela, Esposito, Pasquale, Leoncini, Giovanna, Pontremoli, Roberto, Viazzi, Francesca
Publicado 2023

Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus

por Viazzi, Francesca, Piscitelli, Pamela, Ceriello, Antonio, Fioretto, Paola, Giorda, Carlo, Guida, Pietro, Russo, Giuseppina, De Cosmo, Salvatore, Pontremoli, Roberto
Publicado 2017

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

por Mirijello, Antonio, Viazzi, Francesca, Fioretto, Paola, Giorda, Carlo, Ceriello, Antonio, Russo, Giuspina T., Guida, Pietro, Pontremoli, Roberto, De Cosmo, Salvatore
Publicado 2018

Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?

por Leoncini, Giovanna, Barnini, Cecilia, Manco, Luca, Nobili, Giulia, Dotta, Daniele, Penso, Martina, Russo, Elisa, Cappadona, Francesca, Viazzi, Francesca, Pontremoli, Roberto
Publicado 2022

Metabolic syndrome, serum uric acid and renal risk in patients with T2D

por Viazzi, Francesca, Piscitelli, Pamela, Giorda, Carlo, Ceriello, Antonio, Genovese, Stefano, Russo, Giuseppina, Guida, Pietro, Fioretto, Paola, De Cosmo, Salvatore, Pontremoli, Roberto
Publicado 2017